1. Home
  2. CNTB vs STEM Comparison

CNTB vs STEM Comparison

Compare CNTB & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • STEM
  • Stock Information
  • Founded
  • CNTB 2012
  • STEM 2009
  • Country
  • CNTB United States
  • STEM United States
  • Employees
  • CNTB N/A
  • STEM N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • STEM Computer Software: Prepackaged Software
  • Sector
  • CNTB Health Care
  • STEM Technology
  • Exchange
  • CNTB Nasdaq
  • STEM Nasdaq
  • Market Cap
  • CNTB 114.8M
  • STEM 121.5M
  • IPO Year
  • CNTB 2021
  • STEM N/A
  • Fundamental
  • Price
  • CNTB $1.57
  • STEM $14.82
  • Analyst Decision
  • CNTB Strong Buy
  • STEM Hold
  • Analyst Count
  • CNTB 2
  • STEM 7
  • Target Price
  • CNTB $7.50
  • STEM $10.86
  • AVG Volume (30 Days)
  • CNTB 184.6K
  • STEM 205.4K
  • Earning Date
  • CNTB 09-05-2025
  • STEM 10-29-2025
  • Dividend Yield
  • CNTB N/A
  • STEM N/A
  • EPS Growth
  • CNTB N/A
  • STEM N/A
  • EPS
  • CNTB N/A
  • STEM N/A
  • Revenue
  • CNTB $1,965,000.00
  • STEM $156,002,000.00
  • Revenue This Year
  • CNTB N/A
  • STEM $11.45
  • Revenue Next Year
  • CNTB N/A
  • STEM $18.03
  • P/E Ratio
  • CNTB N/A
  • STEM N/A
  • Revenue Growth
  • CNTB N/A
  • STEM N/A
  • 52 Week Low
  • CNTB $1.56
  • STEM $5.81
  • 52 Week High
  • CNTB $2.20
  • STEM $33.60
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 39.75
  • STEM 53.01
  • Support Level
  • CNTB $1.63
  • STEM $13.14
  • Resistance Level
  • CNTB $1.79
  • STEM $14.88
  • Average True Range (ATR)
  • CNTB 0.18
  • STEM 1.00
  • MACD
  • CNTB -0.04
  • STEM -0.23
  • Stochastic Oscillator
  • CNTB 0.39
  • STEM 41.33

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

Share on Social Networks: